Alkermes plc Overview
Alkermes plc (ALKS) has a P/E ratio of 117.64, above the Healthcare sector average of 26.85.
Get informed when a big investor buys or sells
+ Follow117.64
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, ALKS shows a P/E ratio of 117.64. That is above the Healthcare sector average of 26.85. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 26.85. Alkermes plc is at 117.64, which is higher that average. That is roughly 338.2% above the sector mean. Use the comparison chart on this page to see how ALKS stacks up against individual peers as well.
Investors watch ALKS's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Alkermes plc's latest reading is 117.64. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Alkermes plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 117.64) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 26.85, while ALKS is at 117.64. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
